BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15371876)

  • 1. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
    Jia L; Zhang MH; Yuan SZ; Huang WG
    World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.
    Muramaki M; Miyake H; Hara I; Kamidono S
    Int J Oncol; 2005 Mar; 26(3):623-8. PubMed ID: 15703816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2003 Feb; 9(2):886-99. PubMed ID: 12576464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
    Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
    Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
    Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
    Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of angiogenesis inhibitor TNP-470 on human ACHN renal cell carcinoma.
    Zeng J; Mei W; Huang H; Li X; Kong P
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):331-3. PubMed ID: 12674772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells.
    Miyake H; Eto H; Hara I; So A; Li D; Gleave ME
    J Urol; 2004 Jun; 171(6 Pt 1):2477-81. PubMed ID: 15126879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
    Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNP-470 promotes initial vascular sprouting in xenograft tumors.
    Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
    Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
    Takei H; Lee ES; Cisneros A; Jordan VC
    Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice.
    Huang ZH; Fan YF; Xia H; Feng HM; Tang FX
    World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine.
    Wang XF; Tu LF; Wang LH; Zhou JY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):837-43. PubMed ID: 16972327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
    Teicher BA; Holden SA; Dupuis NP; Kakeji Y; Ikebe M; Emi Y; Goff D
    Breast Cancer Res Treat; 1995; 36(2):227-36. PubMed ID: 8534870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.